|
Issue |
Title |
|
No 7 (2021) |
Parallels of infections of diabetic foot syndrome at inpatient and outpatient stages of treatment |
Abstract
PDF (Rus)
|
A. B. Zemlianoi, T. A. Zelenina, V. V. Salukhov |
|
No 7 (2020) |
Diagnosis and treatment of the early stages of diabetic polyneuropathy |
Abstract
PDF (Rus)
|
V. N. Khramilin, A. N. Zavyalov, I. Yu. Demidova |
|
No 7 (2020) |
The effect of glycated hemoglobin variability on the development of microvascular complications in patients with type 1 diabetes |
Abstract
PDF (Rus)
|
L. L. Bolotskaya, Yu. Yu. Golubkina, A. A. Tolkacheva, L. N. Nikankina |
|
No 4 (2019) |
Painful diabetic polyneuropathy: from clinical guidelines to daily practice |
Abstract
PDF (Rus)
|
V. N. Khramilin, I. Yu. Demidova, A. N. Zavialov |
|
No 4 (2019) |
10-year fracture risk (FRAX®), mineral bone density and trabecular bone index in women with type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
E. S. Mazurenko, O. D. Rymar, L. V. Scherbakova, Y. V. Khrapova, M. P. Isayeva, I. V. Munts, J. Hubacek, M. Bobak, S. K. Malutina |
|
No 4 (2018) |
Complications in diabetes mellitus: diabetic neuropathy focus |
Abstract
PDF (Rus)
|
E. V. Biryukova |
|
No 4 (2018) |
Statines in treatment of patients with diabetes mellitus: niche of atorvastatine |
Abstract
PDF (Rus)
|
S. A. Urazgildeeva |
|
No 4 (2018) |
Mineral-bone disorders in patients with chronic kidney disease and diabetes mellitus: the real possibilities of cardio and nephroprotection. |
Abstract
PDF (Rus)
|
N. G. Mokrysheva, I. S. Maganeva |
|
No 3 (2017) |
THE ROLE OF DYSLIPIDEMIA IN THE PROGRESSION OF DIABETIC RETINOPATHY |
Abstract
PDF (Rus)
|
A. G. Kuzmin, S. A. Martynov, M. V. Shestakova |
|
No 3 (2017) |
THE ROLE OF GLYCATED HEMOGLOBIN IN THE DIAGNOSIS AND IMPROVED PROGNOSIS OF DIABETES MELLITUS |
Abstract
PDF (Rus)
|
E. V. Biryukova |
|
No 3 (2017) |
CHANGES OF SKIN AND ORAL MUCOSA IN DIABETES MELLITUS AND THEIR PREVENTION |
Abstract
PDF (Rus)
|
A. F. Verebovoy, L. A. Sharonova, S. A. Burakshaev, E. V. Kotelnikova |
|
No 3 (2016) |
Cardiovascular safety in the treatment of diabetes mellitus type 2: focus on alogliptin |
Abstract
PDF (Rus)
|
A. L. Terekhova, N. A. Petunina |
|
No 3 (2016) |
The specific treatment of dyslipidemia in patients with diabetes type 2 |
Abstract
PDF (Rus)
|
S. A. Urazgildeeva , O. F. Malygina |
|
1 - 13 of 13 Items |
|